Alex A. Adjei, Rochester, USA
Román Perez Soler, New York, USA
Antoni Ribas, Los Angeles, USA
Josep Tabernero, Barcelona, Spain
ACHO (Asociación Colombiana de Hematología y Oncología)
INC (Instituto Nacional del Cáncer Argentina)
SAH (Sociedad Argentina de Hematologia)
SBOC (Sociedade Brasileira de Oncologia Clínica)
SMEO (Sociedad Mexicana de Oncología)
SPOM (Sociedad Peruana de Oncología Médica)
RECOMMENDED BY :
ESO (European Society of Oncology)
Alex A. Adjei, MD, Ph.D
Consultant in Oncology
Professor of Oncology
Mayo Clinic
Rochester, Minnesota, USA
Kenneth C. Anderson, MD
Kraft Family Professor of Medicine
Harvard Medical School
Dana-Farber Cancer Institute
Boston, Massachusetts, USA
Stephen M. Ansell, MD, Ph.D
Professor of Medicine
Chair Lymphoma Group
Mayo Clinic
Rochester, Minnesota, USA
Carlos H. Barrios, MD
Centro de Pesquisa Clínica, Hospital São Lucas, PUCRS
Latin American Cooperative Oncology Group (LACOG)
Porto Alegre RS, Brazil
Joaquim Bellmunt, MD, Ph.D
Director, Bladder Cancer Program
Beth Israel Deaconess Medical Center
Associate Professor, Medicine
Harvard Medical School
Bladder Cancer Center
Dana-Farber Cancer Institute
Boston, Massachusetts, USA
Julie R. Brahmer, MD, MSc
Professor of Oncology
Co-Leader of the Cancer Immunology Program
Director of the Thoracic Oncology Program
Director of the Sidney Kimmel Cancer Center at Johns Hopkins Bayview
Sidney Kimmel Comprehensive Cancer Center
Johns Hopkins School of Medicine
Baltimore, Maryland, USA
Robert L. Coleman, MD , FACOG, FACS
Gynecologic Oncologist
Chief Scientific Officer
US Oncology Research
The Woodlands, Texas, USA
Jorge Cortes, MD
Professor of Medicine
Director, Georgia Cancer Center
Cecil F. Whitaker Jr.
GRA Eminent Scholar Chair in Cancer
Augusta, Georgia, USA
Johann de Bono, MD, MSc, PhD, FRCP, FMedSci
Regius Professor of Cancer Research
Professor of Experimental Cancer Medicine
Director of the Drug Development Unit and Head of the Prostate Cancer Targeted Therapy Group
The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust
Sutton, Surrey, United Kingdom
Enriqueta Felip, MD, Ph.D
Head, Thoracic and H&N Cancer Group
Oncology Department
Vall d’Hebron University Hospital
Vall d’Hebron Institute of Oncology (VHIO)
Barcelona, Spain
Guillermo Garcia-Manero, MD
Professor, Department of Leukemia, Division of Cancer Medicine
Syndromes and Chronic Myelomonocytic Leukemia (MDS-CMML)
Deputy Chair, Translational Research ,Department of Leukemia
The University of Texas MD Anderson Cancer Center,
Houston, Texas, USA
Josep M Llovet, MD, PhD, FAASLD
Professor of Medicine.
Director, Mount Sinai Liver Cancer Program
Division of Liver Diseases
Tisch Cancer Institute
Icahn School of Medicine at Mount Sinai
New York, New York, USA
Ingrid A. Mayer, MD, MSCI
Ingram Professor of Cancer Research
Professor of Medicine
Leader, VICC Breast Cancer Research Program
Co-Principal Investigator, VICC Breast Cancer SPORE
Division of Hematology/ Oncology
Vanderbilt University Medical Center
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, USA
Jarushka Naidoo, MB, BCH, MHS
Consultant Medical Oncologist, Beaumont Hospital Dublin
Lung Cancer Lead, Clinical Trials Ireland
Dublin, Ireland
Adjunct Assistant Professor of Oncology
Johns Hopkins University
Baltimore, Maryland, USA
Luis Paz-Ares, MD Ph.D
Head of Medical Oncology Department
Hospital Universitario 12 de Octubre
Associate Professor
Universidad Complutense de Madrid
Madrid, Spain
Roman Perez-Soler, MD
Chairman, Department of Oncology
Montefiore Medical Center
Professor of Medicine and Molecular Pharmacology
Deputy Cancer Center Director
Albert Einstein College of Medicine
Bronx, New York, USA
Antoni Ribas, MD, Ph.D
Professor of Medicine and Surgery
Professor of Molecular and Medical Pharmacology
Director Tumor Immunology Program, Jonsson
Comprehensive Cancer Center (JCCC)
David Geffen School of Medicine, UCLA
Chair, Melanoma Committee at SWOG
Los Angeles, California, USA
Christian Rolfo, MD, PhD, MBA, Dr.h.c.
Professor of Medicine
Associate Director of Clinical Research
Center for Thoracic Oncology, Tisch Cancer Institute
Mount Sinai System & Icahn School of Medicine
New York, NY, USA
Josep Tabernero, MD, Ph.D,
Head, Medical Oncology Department
Vall d’Hebron University Hospital (HUVH)
Director, Vall d’Hebron Institute of Oncology (VHIO)
Vall d’Hebron Hospital Campus
Professor of Medicine, UVic-UCC
Barcelona, Spain
PLATINUM SPONSORS
GOLD SPONSORS
